Sale!

SLC33A1 Gene SPG42 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC33A1 gene, associated with SPG42 (Spastic Paraplegia 42), is crucial for understanding and managing this rare hereditary disorder. SPG42 is characterized by progressive weakness and stiffness of the legs, resulting from the degeneration of nerve cells that control muscle movement and coordination. The genetic test for SPG42, focusing on the SLC33A1 gene, is an essential diagnostic tool for individuals showing symptoms of this condition or those with a family history of hereditary spastic paraplegia.

Conducted at DNA Labs UAE, the test for the SLC33A1 gene associated with SPG42 involves analyzing the patient’s DNA to identify mutations in the SLC33A1 gene that could lead to the disorder. This precise genetic testing can confirm a diagnosis of SPG42, allowing for appropriate management and treatment plans to be developed. It can also provide valuable information for family planning and genetic counseling for affected families.

The cost of the SLC33A1 gene SPG42 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations within the SLC33A1 gene that are responsible for SPG42. By opting for this test, patients and their families can gain insights into the genetic basis of the condition, enabling informed decisions about care and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC33A1 Gene SPG42 Genetic Test

At DNA Labs UAE, we offer the SLC33A1 Gene SPG42 Genetic Test for individuals suspected of having spastic paraplegia type 42 (SPG42), a rare genetic disorder characterized by progressive muscle stiffness and weakness in the lower limbs.

Test Details

The SLC33A1 gene is associated with SPG42. Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously to identify mutations or variations in the SLC33A1 gene that may be responsible for the development of the condition.

This test can help confirm a diagnosis and provide information about the specific genetic cause of SPG42 in an individual. It can also be used for carrier testing in family members and for genetic counseling purposes.

Test Components and Price

Test Name: SLC33A1 Gene SPG42 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition

We accept the following sample conditions:

  • Blood
  • Extracted DNA
  • One drop of blood on FTA Card

Report Delivery

Once the sample is received, the report will be delivered within 3 to 4 weeks.

Test Type

This test is specifically designed for individuals with neurological disorders, such as SPG42.

Referring Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the SLC33A1 Gene SPG42 NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SPG42.

This information is crucial for accurate diagnosis and interpretation of the test results.

For more information or to schedule an appointment, please contact DNA Labs UAE.

Test Name SLC33A1 Gene SPG42 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC33A1 Gene SPG42 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC33A1 Gene SPG42
Test Details

The SLC33A1 gene is associated with a condition called spastic paraplegia type 42 (SPG42). SPG42 is a rare genetic disorder characterized by progressive muscle stiffness and weakness in the lower limbs, leading to difficulty walking.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously for genetic mutations or variations. In the case of SPG42, NGS genetic testing can be used to identify mutations or variations in the SLC33A1 gene that may be responsible for the development of the condition. This type of testing can help confirm a diagnosis and provide information about the specific genetic cause of SPG42 in an individual. It can also be used for carrier testing in family members and for genetic counseling purposes.